{
  "question_id": "hpmcq24027",
  "category": "hp",
  "educational_objective": "Evaluate laboratory test results in a patient with suspected hereditary hemochromatosis.",
  "metadata": {
    "care_types": [],
    "patient_types": [],
    "high_value_care": false,
    "question_updated": "12/25/2025"
  },
  "question_text": "A 44-year-old man is evaluated because of persistent abnormal liver test results. He is asymptomatic. He drinks five cans of beer daily. He is of northern European descent and has no known family history of liver disease. His only medical condition is obesity, and he takes no medications.On physical examination, vital signs and other findings are normal.Laboratory studies:Platelet count432,000/μL (432 × 109/L)Albumin4.4 g/dL (44 g/L)Alkaline phosphatase98 U/LHAlanine aminotransferase96 U/LHAspartate aminotransferase87 U/LHBilirubinTotal0.8 mg/dL (13.6 µmol/L)Direct0.5 mg/dL (8.5 µmol/L)HIron229 µg/dL (40.9 µmol/L)HTotal iron-binding capacity280 µg/dL (50.1 µmol/L)Transferrin saturation81.7%HFerritin822 ng/mL (822 µg/L)H HFE gene variant testingC282Y heterozygousResults of viral hepatitis, autoimmune hepatitis, and Wilson disease testing are negative.Ultrasound of the abdomen shows increased liver echogenicity consistent with steatosis.",
  "question_stem": "Which of the following is the most appropriate next step in management?",
  "options": [
    {
      "letter": "A",
      "text": "Lifestyle modifications",
      "peer_percentage": 0
    },
    {
      "letter": "B",
      "text": "Liver biopsy with hepatic iron quantification",
      "peer_percentage": 0
    },
    {
      "letter": "C",
      "text": "Liver MRI with hepatic iron quantification",
      "peer_percentage": 0
    },
    {
      "letter": "D",
      "text": "Therapeutic phlebotomy",
      "peer_percentage": 0
    }
  ],
  "user_performance": {
    "user_answer": null,
    "correct_answer": "A",
    "result": null,
    "time_taken": null
  },
  "critique": "The most appropriate next step in management is lifestyle modifications (Option A). This patient has mildly elevated aminotransferase levels in a hepatocellular pattern of injury, as well as elevated transferrin saturation and ferritin levels. The differential diagnosis includes the following:Hereditary hemochromatosis (HH)Alcoholic liver diseaseMetabolic dysfunction–associated steatotic liver disease (MASLD, formerly termed nonalcoholic fatty liver disease [NAFLD])HH is an autosomal recessive condition characterized by excessive accumulation of iron in the liver due to a variant in the genes that control hepcidin synthesis, resulting in increased intestinal iron absorption. HH is most commonly associated with C282Y homozygosity or, less often, with C282Y/H63D compound heterozygosity. The prevalence of the C282Y allele is around 5% to 10% among individuals of northern European ancestry, such as this patient. This patient's HFE gene variant testing demonstrates C282Y heterozygosity, which is not associated with HH. MASLD and alcoholic liver disease are more likely causes of this patient's presentation, and the most appropriate management is to counsel him regarding lifestyle modifications, including weight loss and stopping alcohol use. If this patient's iron levels remain elevated despite lifestyle modifications, investigation for tissue iron overload, such as with liver biopsy or MRI, would be indicated.Liver biopsy with hepatic iron quantification (Option B) is not indicated in this case because the patient does not have a pathogenic HFE genotype associated with iron overload. Patients with HH who have a ferritin level greater than 1000 ng/mL (1000 µg/L) or abnormal aminotransferase levels at the time of diagnosis should undergo further testing for cirrhosis; a liver biopsy for fibrosis assessment and measurement of hepatic iron content should be considered in that setting.Liver MRI with hepatic iron quantification (Option C) is inappropriate in this case because the patient does not have a pathogenic HFE genotype associated with iron overload. In patients with an HFE genotype associated with iron overload, MRI can be used to estimate tissue iron content as an alternative to liver biopsy.Beginning therapeutic phlebotomy (Option D) is not indicated because the patient does not have HH and does not have increased total body stores of iron. The elevated iron studies observed in some patients with MASLD or alcoholic liver disease are most likely due to systemic inflammation. Therapeutic phlebotomy for hyperferritinemia in MASLD or alcoholic liver disease is not currently recommended.",
  "key_points": [
    "Hereditary hemochromatosis is most commonly associated with C282Y homozygosity or, less often, with C282Y/H63D compound heterozygosity."
  ],
  "references": "Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019;114:1202-1218. PMID: 31335359 doi:10.14309/ajg.0000000000000315",
  "related_content": {
    "syllabus": [
      "hpsec24004_24003"
    ],
    "learning_plan_topic": ""
  },
  "media": {
    "tables": [],
    "images": [],
    "svgs": [],
    "videos": []
  },
  "extracted_at": "2025-12-25T19:50:07.854797-06:00"
}